Press Release | March 1, 2023
DICE Therapeutics Announces Late-Breaking Presentation at the 2023 American Academy of Dermatology (AAD) Annual Meeting
Read More
News | February 27, 2023
Pathway to Cures Appoints Investment Committee
Read More
Press Release | February 2, 2023
Pliant Therapeutics Announces FDA Clearance of Investigational New Drug Application for PLN-101095, A Novel Integrin Inhibitor for the Treatment of Solid Tumors
Read More
Press Release | February 1, 2023
Dr. Joseph E. Eid, Who Led Merck’s Pioneering Clinical Development of KEYTRUDA®, joins Dragonfly Therapeutics as President of R&D
Read More
